NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 130 filers reported holding NURIX THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $59,170 | +83.3% | 2,835,119 | +29.1% | 0.01% | +75.0% |
| Q1 2024 | $32,284 | +30.9% | 2,196,169 | -8.1% | 0.00% | +33.3% |
| Q4 2023 | $24,665 | +32.0% | 2,389,966 | +0.5% | 0.00% | 0.0% |
| Q3 2023 | $18,692 | -21.4% | 2,377,978 | -0.1% | 0.00% | 0.0% |
| Q2 2023 | $23,776 | +3.6% | 2,379,873 | -7.9% | 0.00% | 0.0% |
| Q1 2023 | $22,954 | -35.7% | 2,584,751 | -20.6% | 0.00% | -50.0% |
| Q4 2022 | $35,726 | -99.9% | 3,253,736 | -9.8% | 0.01% | -25.0% |
| Q3 2022 | $46,991,000 | -19.7% | 3,606,352 | -22.0% | 0.01% | +14.3% |
| Q2 2022 | $58,546,000 | -13.1% | 4,620,823 | -3.9% | 0.01% | 0.0% |
| Q1 2022 | $67,336,000 | -52.3% | 4,806,289 | -1.3% | 0.01% | -46.2% |
| Q4 2021 | $141,018,000 | -0.3% | 4,871,084 | +3.2% | 0.01% | 0.0% |
| Q3 2021 | $141,378,000 | +31.5% | 4,718,877 | +16.5% | 0.01% | +30.0% |
| Q2 2021 | $107,486,000 | +11.8% | 4,051,478 | +31.0% | 0.01% | 0.0% |
| Q1 2021 | $96,183,000 | +394.4% | 3,093,705 | +422.9% | 0.01% | +400.0% |
| Q4 2020 | $19,453,000 | -1.0% | 591,636 | +5.1% | 0.00% | 0.0% |
| Q3 2020 | $19,645,000 | – | 562,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,422,549 | $90,800,000 | 15.85% |
| Ponoi II Management, LLC | 686,274 | $18,207,000 | 14.76% |
| Ponoi Management, LLC | 686,274 | $18,207,000 | 10.12% |
| Foresite Capital Management V, LLC | 451,522 | $11,979,000 | 4.71% |
| Foresite Capital Management IV, LLC | 1,205,798 | $31,990,000 | 4.32% |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $34,073,000 | 2.23% |
| EcoR1 Capital, LLC | 1,967,950 | $52,210,000 | 1.95% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 571,212 | $15,155,000 | 1.93% |
| DAFNA Capital Management LLC | 306,320 | $8,127,000 | 1.70% |
| Euclidean Capital LLC | 154,426 | $4,097,000 | 1.33% |